Moors & Cabot’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELAN
Moors & Cabot's ELAN Position: Q2 2026 in Review
Moors & Cabot reduced its Elanco Animal Health (ELAN) stake by 5.3% in Q2 2026, selling an estimated $10.4K and leaving 8,139 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #900.
Moors & Cabot first reported a position in ELAN in Q3 2019 and has held it in 20 quarters since. The position peaked at $977K in Q3 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- Moors & Cabot held 8,139 shares of Elanco Animal Health worth $200K as of Q2 2026.
- Moors & Cabot sold 451 Elanco Animal Health shares in Q2 2026, an estimated $10.4K.
- Elanco Animal Health made up 0.01% of Moors & Cabot's portfolio in Q2 2026, its #900 holding.
- Moors & Cabot first reported a position in Elanco Animal Health in Q3 2019 and has held it in 20 quarters since.
- Moors & Cabot's Elanco Animal Health position peaked at $977K in Q3 2021.
- 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.